Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

1,285.00p
   
  • Change Today:
      35.00p
  • 52 Week High: 1,430.00
  • 52 Week Low: 367.50
  • Currency: UK Pounds
  • Shares Issued: 48.75m
  • Volume: 31,308
  • Market Cap: £626.48m
  • Beta: 0.01

Latest ShareCast News

Ergomed sets up new PrimeVigilance subsidiary in Japan

By Iain Gilbert

Date: Monday 26 Apr 2021

(Sharecast News) - Pharmaceutical industry services provider Ergomed said on Monday that its PrimeVigilance business has established a new legal entity and a regional office in Japan.

Tuesday broker round-up

By Caoimhe Toman

Date: Tuesday 23 Mar 2021

(Sharecast News) - Fevertree: Barclays upgrades to buy with a target price of 2,500p.

Pharmacovigilance drives growth at Ergomed

By Josh White

Date: Tuesday 23 Mar 2021

(Sharecast News) - Pharmaceutical services company Ergomed reported a 26.5% increase in revenue in its full-year results on Tuesday, to £86.4m.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ergomed Market Data

Currency UK Pounds
Share Price 1,285.00p
Change Today 35.00p
% Change 2.80 %
52 Week High 1,430.00
52 Week Low 367.50
Volume 31,308
Shares Issued 48.75m
Market Cap £626.48m
Beta 0.01

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.69% below the market average96.69% below the market average96.69% below the market average96.69% below the market average96.69% below the market average
96.15% below the sector average96.15% below the sector average96.15% below the sector average96.15% below the sector average96.15% below the sector average
Price Trend
91.40% above the market average91.40% above the market average91.40% above the market average91.40% above the market average91.40% above the market average
85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average
Income Not Available
Growth
92.74% above the market average92.74% above the market average92.74% above the market average92.74% above the market average92.74% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 17-May-2021

Time Volume / Share Price
14:44 194 @ 1,292.50p
14:44 278 @ 1,292.50p
14:44 347 @ 1,290.00p
14:44 47 @ 1,285.00p
14:44 501 @ 1,300.00p

Ergomed Key Personnel

CFO Richard Barfield
COO Lewis Cameron

Top of Page